Panorama – the non-invasive prenatal genetic testing – has new screening options

A genetic test analyses part of the DNA and is a very important resource when it comes to screening mutations in a certain gene or chromosome. Genetic alterations, commonly referred to as mutations, may affect all cells in our body and be passed on to future generations.

The Panorama TM – Prenatal Test is now available at Joaquim Chaves Saúde with new screening options and at more competitive prices. It is now possible to detect most common foetal trisomies as early as 9 weeks of pregnancy.

Screening options for Panorama Test are the following:

• Standard: screening for T21, T18, T13, Triploidy and Sex Chromosome Anomalies;

• DiGeorge:screening for T21, T18, T13, Triploidy, Sex Chromosome Anomalies and DiGeorge Syndrome (22q11.2 deletion syndrome), the most frequent microdeletion syndrome;

• Microdeletions: screening for T21, T18, T13, Triploidy, Sex Chromosome Anomalies and some of the most common and severe MicrodeletionSyndromes, namely, DiGeorge (22q11.2 deletion syndrome), Prader-Willi, Angelman, Cri du-Chat and 1p36 deletion.

You may add determination of foetal gender, to any of the above mentioned screening options, with no extra costs involved.

A PanoramaTM non-invasive prenatal genetic testing and screening with a “high risk” result means there is a high-chance likelihood that the foetus has the detected mutation. However, this test is not a diagnostic procedure, which means all results presented as “high risk” should be confirmed with a foetal sample – amniotic fluid or chorionic villus. Should this be the case, and being aware of the urgent need for a conclusive result allowing a timely decision on the course of gestation, we are committed to quickly confirming the detected aneuploidy or microdeletion syndrome, as well as the foetal karyotype. 

No extra costs involved.

If you need more information on this matter, please contact JCS Medical Genetics service at (00351) 214 124 331.